Molecular Profiling of Inflammatory Breast Cancer
暂无分享,去创建一个
Rosette Lidereau | M. Espié | I. Bièche | M. Marty | S. Tozlu | R. Lidereau | F. Lerebours | Florence Lerebours | Marc Espie | Michel Marty | Ivan Bièche | Sengül Tozlu
[1] H. B. Mann,et al. On a Test of Whether one of Two Random Variables is Stochastically Larger than the Other , 1947 .
[2] T. Iwanaga,et al. Absence of endothelial cells, central necrosis, and fibrosis are associated with aggressive inflammatory breast cancer. , 2001, Cancer research.
[3] Monilola A. Olayioye,et al. The ErbB signaling network: receptor heterodimerization in development and cancer , 2000, The EMBO journal.
[4] S. Tommasi,et al. Cell kinetics and hormonal receptor status in inflammatory breast carcinoma. Comparison with locally advanced disease , 1989, Cancer.
[5] J. Hanley,et al. The meaning and use of the area under a receiver operating characteristic (ROC) curve. , 1982, Radiology.
[6] E. Wagner,et al. AP-1 in mouse development and tumorigenesis , 2001, Oncogene.
[7] S. Merajver,et al. Molecular biology of breast cancer metastasis: Inflammatory breast cancer: clinical syndrome and molecular determinants , 2000, Breast Cancer Research.
[8] M. Klagsbrun,et al. AP-1 mediates stretch-induced expression of HB-EGF in bladder smooth muscle cells. , 1999, American journal of physiology. Cell physiology.
[9] G. Hortobagyi,et al. Update on the management of inflammatory breast cancer. , 2003, The oncologist.
[10] A. Buzdar,et al. Inflammatory breast carcinoma incidence and survival , 1998, Cancer.
[11] Robert J. Wechsler-Reya,et al. Transcriptional profiling of the Sonic hedgehog response: A critical role for N-myc in proliferation of neuronal precursors , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[12] S. Merajver,et al. A novel putative low-affinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPase correlate with the inflammatory breast cancer phenotype. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[13] L. Penland,et al. Use of a cDNA microarray to analyse gene expression patterns in human cancer , 1996, Nature Genetics.
[14] Adrian L. Harris,et al. Hypoxia — a key regulatory factor in tumour growth , 2002, Nature Reviews Cancer.
[15] I. Bièche,et al. Real-time reverse transcription-PCR assay for future management of ERBB2-based clinical applications. , 1999, Clinical chemistry.
[16] S. Devesa,et al. Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute. , 2005, Journal of the National Cancer Institute.
[17] Andrew J. Dannenberg,et al. Regulation of Cyclooxgenase-2 mRNA Stability by Taxanes , 2003, Journal of Biological Chemistry.
[18] Olivier Cussenot,et al. Gene expression profiling in clinically localized prostate cancer: a four-gene expression model predicts clinical behavior. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[19] R. Davis,et al. Independent regulation of JNK/p38 mitogen-activated protein kinases by metabolic oxidative stress in the liver. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[20] Elisabeth Remy,et al. GeneANOVA-gene expression analysis of variance , 2002, Bioinform..
[21] Nigel Mackman,et al. Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress , 2000, Nature Medicine.
[22] W. Kruskal,et al. Use of Ranks in One-Criterion Variance Analysis , 1952 .
[23] P. Iannaccone,et al. The sonic hedgehog-patched-gli pathway in human development and disease. , 2000, American journal of human genetics.
[24] Gregory Y. Lauwers,et al. Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis , 2003, Nature.
[25] G. Hortobagyi,et al. Inflammatory breast cancer: a review. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] S. Barsky,et al. A novel human xenograft model of inflammatory breast cancer. , 1999, Cancer research.
[27] Christophe Laurent,et al. Molecular profiling of hepatocellular carcinomas (HCC) using a large-scale real-time RT-PCR approach: determination of a molecular diagnostic index. , 2003, The American journal of pathology.
[28] J. Gutkind,et al. Multiple Mitogen-Activated Protein Kinase Signaling Pathways Connect the Cot Oncoprotein to the c-junPromoter and to Cellular Transformation , 2000, Molecular and Cellular Biology.
[29] E. Vellenga,et al. c-Jun and c-Fos cooperate with STAT3 in IL-6-induced transactivation of the IL-6 respone element (IRE). , 2001, Cytokine.
[30] E. van Marck,et al. Inflammatory breast cancer shows angiogenesis with high endothelial proliferation rate and strong E-cadherin expression , 2003, British Journal of Cancer.
[31] M. Espié,et al. Increased incidence of ERBB2 overexpression and TP53 mutation in inflammatory breast cancer , 2002, Oncogene.
[32] I. Bièche,et al. Identification of CGA as a novel estrogen receptor-responsive gene in breast cancer: an outstanding candidate marker to predict the response to endocrine therapy. , 2001, Cancer research.